Osaic Holdings
AMRX icon

Osaic Holdings’s Amneal Pharmaceuticals AMRX Stock Holding History

Osaic Holdings’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
134,620
+132,640
+6,699% +$1.82M ﹤0.01% 2175
2026
Q1 		$24.6K Buy
1,980
+565
+40% +$7.59K ﹤0.01% 5726
2025
Q4 		$17.8K Sell
1,415
-912
-39% -$10.4K ﹤0.01% 5946
2025
Q3 		$22.7K Buy
2,327
+2
+0.1% +$18 ﹤0.01% 5848
2025
Q2 		$18.8K Sell
2,325
-2,575
-53% -$19.4K ﹤0.01% 5763
2025
Q1 		$41.1K Sell
4,900
-2,425
-33% -$20.2K ﹤0.01% 4863
2024
Q4 		$58K Sell
7,325
-1,121
-13% -$9.4K ﹤0.01% 4599
2024
Q3 		$70.3K Sell
8,446
-240
-3% -$1.88K ﹤0.01% 4490
2024
Q2 		$55.2K Buy
8,686
+2,840
+49% +$18K ﹤0.01% 4604
2024
Q1 		$35.4K Buy
5,846
+1,100
+23% +$6.2K ﹤0.01% 4975
2023
Q4 		$28.8K Sell
4,746
-13,999
-75% -$62.4K ﹤0.01% 5275
2023
Q3 		$79.1K Sell
18,745
-32,060
-63% -$120K ﹤0.01% 4680
2023
Q2 		$154K Sell
50,805
-5,445
-10% -$11.6K ﹤0.01% 4102
2023
Q1 		$78.2K Buy
56,250
+851
+2% +$1.69K ﹤0.01% 4637
2022
Q4 		$111K Sell
55,399
-3,091
-5% -$6.93K ﹤0.01% 4346
2022
Q3 		$118K Buy
58,490
+3
+0% +$8 ﹤0.01% 4227
2022
Q2 		$192K Sell
58,487
-2
-0% -$7 ﹤0.01% 3833
2022
Q1 		$127K Buy
58,489
+134
+0.2% +$593 ﹤0.01% 4391
2021
Q4 		$282K Buy
58,355
+1,999
+4% +$9.97K ﹤0.01% 3633
2021
Q3 		$309K Buy
56,356
+2,362
+4% +$11.9K ﹤0.01% 3517
2021
Q2 		$283K Buy
53,994
+11,637
+27% +$66.1K ﹤0.01% 3573
2021
Q1 		$280K Buy
42,357
+5,836
+16% +$32.3K ﹤0.01% 3447
2020
Q4 		$167K Sell
36,521
-11,702
-24% -$51.9K ﹤0.01% 3629
2020
Q3 		$223K Buy
48,223
+141
+0.3% +$603 ﹤0.01% 3149
2020
Q2 		$228K Buy
48,082
+5,698
+13% +$23.5K ﹤0.01% 3010
2020
Q1 		$135K Buy
+42,384
New +$179K ﹤0.01% 3225

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Osaic Holdings's AMRX Position: Q2 2026 in Review

Osaic Holdings increased its Amneal Pharmaceuticals (AMRX) stake by 6,699% in Q2 2026, buying an estimated $1.82M and bringing the position to 134,620 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

Osaic Holdings first reported a position in AMRX in Q1 2020 and has held it in 26 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Osaic Holdings held 134,620 shares of Amneal Pharmaceuticals worth $2.33M as of Q2 2026.
  • Osaic Holdings bought 132,640 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2175 holding.
  • Osaic Holdings first reported a position in Amneal Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.